Neuronetics (STIM) Cash & Current Investments (2017 - 2026)

Neuronetics (STIM) has 10 years of Cash & Current Investments data on file, last reported at $6.0 million in Q1 2026.

• On a quarterly basis, Cash & Current Investments rose 200.35% year-over-year to $6.0 million in Q1 2026; TTM through Mar 2026 was $6.0 million, a 200.35% increase from a year earlier, with the FY2025 full-year figure at $6.2 million, up 416.17% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $6.0 million, down from $6.2 million in the prior quarter.
• Over the last five years, Cash & Current Investments for STIM reached as high as $83.0 million in Q1 2022 and fell as low as $1.2 million in Q4 2024.
• Historically, Cash & Current Investments has averaged $38.3 million across 5 years, with a median of $43.3 million in 2024.
• Across the five-year window, Cash & Current Investments sank 98.01% in 2024 and jumped 416.17% in 2025, its largest moves.
• Year by year, Cash & Current Investments stood at $71.9 million in 2022, then retreated by 15.72% to $60.6 million in 2023, then sank by 98.01% to $1.2 million in 2024, then soared by 416.17% to $6.2 million in 2025, then dropped by 3.5% to $6.0 million in 2026.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $6.0 million in Q1 2026, $6.2 million in Q4 2025, and $6.7 million in Q3 2025.